However, CGRP failed to alter the proliferation rate of cells from human prostate cancer cell line LNCaP and human breast cancer cell line MCF-7, which are known to have lower metastatic potential (Ravenna et al, 2014; Comşa et al, 2015; Sun et al, 2016). This evidence concerns the gene CALCA and prostate carcinoma.